{
    "organizations": [],
    "uuid": "018f177ebd6d2aa19c613bb4cf4b2a799e8b0dad",
    "author": "",
    "url": "https://www.reuters.com/article/brief-hls-therapeutics-announces-normal/brief-hls-therapeutics-announces-normal-course-issuer-bid-idUSFWN1SG1MN",
    "ord_in_thread": 0,
    "title": "BRIEF-HLS Therapeutics Announces Normal Course Issuer Bid",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9 (Reuters) - HLS Therapeutics Inc:\n* HLS THERAPEUTICS ANNOUNCES NORMAL COURSE ISSUER BID * HLS THERAPEUTICS - PURSUANT TO NORMAL COURSE ISSUER BID, CO MAY PURCHASE FOR CANCELLATION UP TO AGGREGATE OF 1.4 MILLION OF ITS ISSUED & OUTSTANDING SHARES Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-10T00:13:00.000+03:00",
    "crawled": "2018-05-10T00:33:30.001+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "hl",
        "therapeutic",
        "inc",
        "hl",
        "therapeutic",
        "announces",
        "normal",
        "course",
        "issuer",
        "bid",
        "hl",
        "therapeutic",
        "pursuant",
        "normal",
        "course",
        "issuer",
        "bid",
        "co",
        "may",
        "purchase",
        "cancellation",
        "aggregate",
        "million",
        "issued",
        "outstanding",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}